SHAPERON INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,105 KRW | +9.86% |
|
+5.30% | -44.02% |
| 03-18 | Shaperon Enrolls its First Patient in Phase 2 U.S. Clinical Trial for Atopic Dermatitis Therapy 'Nugel' | CI |
| 2022 | Shaperon Inc. has completed an IPO in the amount of KRW 13.735 billion. | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Neutral | Bearish |
| Resistance | 2,475.00 | 3,840.00 | 3,485.00 |
| Spread/Res. | -14.95% | -45.18% | -39.60% |
| Spread/Supp. | +34.25% | +34.25% | +29.38% |
| Support | 1,568.00 | 1,568.00 | 1,627.00 |
- Stock Market
- Equities
- A378800 Stock
- Charts Shaperon Inc.